My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 788

    1.

    Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.

    Han W, Wang T, Reilly AA, Keller SM, Spivack SD.

    Respir Res. 2009 Sep 25;10:86.PMID: 19781081 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.

    Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P.

    BMC Cancer. 2007 May 3;7:74.PMID: 17477876 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.

    Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC.

    Cancer. 2007 Nov 1;110(9):2019-26.PMID: 17876837 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

    Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

    Cancer Res. 2002 Apr 15;62(8):2370-7.PMID: 11956099 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.

    Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz AG, Bocklage TJ, Coons TA, Gilliland FD, Belinsky SA.

    Int J Cancer. 2005 Apr 10;114(3):400-5.PMID: 15578700 [PubMed - indexed for MEDLINE]Related articles

    6.

    Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.

    Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S.

    Clin Cancer Res. 2005 Apr 1;11(7):2466-70.PMID: 15814621 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.

    Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L.

    Cancer Res. 2002 Jan 15;62(2):351-5.PMID: 11809677 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.

    Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J.

    Cancer Res. 2003 Jul 1;63(13):3743-6.PMID: 12839968 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Exhaled biomarkers in lung cancer.

    Horváth I, Lázár Z, Gyulai N, Kollai M, Losonczy G.

    Eur Respir J. 2009 Jul;34(1):261-75. Review.PMID: 19567608 [PubMed - indexed for MEDLINE]Related articles

    10.

    Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.

    Conrad DH, Goyette J, Thomas PS.

    J Gen Intern Med. 2008 Jan;23 Suppl 1:78-84. Review.PMID: 18095050 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.

    Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, Kiropoulos T, Tanou K, Gourgoulianis KI, Kostikas K.

    Lung Cancer. 2009 May;64(2):219-25. Epub 2008 Oct 9.PMID: 18845357 [PubMed - indexed for MEDLINE]Related articles

    12.

    Aberrant promoter hypermethylation in serum DNA from patients with silicosis.

    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.

    Carcinogenesis. 2008 Sep;29(9):1845-9. Epub 2008 Jul 16.PMID: 18632757 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).

    Niklinska W, Naumnik W, Sulewska A, Kozłowski M, Pankiewicz W, Milewski R.

    Folia Histochem Cytobiol. 2009;47(2):275-80.PMID: 19926549 [PubMed - in process]Related articles

    14.

    Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?

    Carpagnano GE, Spanevello A, Palladino GP, Gramiccioni C, Ruggieri C, Carpagnano F, Foschino Barbaro MP.

    Lung Cancer. 2010 Jan;67(1):108-13. Epub .PMID: 19423183 [PubMed - indexed for MEDLINE]Related articles

    15.

    Noninvasive detection of lung cancer by analysis of exhaled breath.

    Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A.

    BMC Cancer. 2009 Sep 29;9:348.PMID: 19788722 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Gene promoter methylation in plasma and sputum increases with lung cancer risk.

    Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA.

    Clin Cancer Res. 2005 Sep 15;11(18):6505-11.PMID: 16166426 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.

    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.

    Ann Surg Oncol. 2008 Nov;15(11):3272-7. Epub 2008 Aug 20.PMID: 18712569 [PubMed - indexed for MEDLINE]Related articles

    18.

    3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.

    Carpagnano GE, Foschino-Barbaro MP, Spanevello A, Resta O, Carpagnano F, Mulé G, Pinto R, Tommasi S, Paradiso A.

    Am J Respir Crit Care Med. 2008 Feb 1;177(3):337-41. Epub 2007 Oct 25.PMID: 17962633 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.

    Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, Gabbert HE, Sarbia M.

    Cancer. 2006 Apr 25;108(2):129-34.PMID: 16444703 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.

    Wang Y, Yu Z, Wang T, Zhang J, Hong L, Chen L.

    Lung Cancer. 2007 May;56(2):289-94. Epub 2007 Jan 30.PMID: 17267069 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk